VISTIN PHARMA ASA (VISTN.OL)

Every figure this model derived for VISTN.OL, the value it took, and the element in the company's own XBRL it was read from — so any of it can be checked against the filing rather than taken on trust. As at 2024-12-31.

The figures, and where each came from

This is the part no other screener shows. Each figure below names the XBRL element it was read from, so it can be checked against the filing itself.

FigureValueXBRL tagAs at
cash 12,794,000 CashAndCashEquivalents 2025-01-01
current assets 143,187,000 CurrentAssets 2025-01-01
current liabilities 63,969,000 CurrentLiabilities 2025-01-01
equity 309,529,000 Equity 2025-01-01
interest expense 14,557,000 FinanceCosts 2024-12-31
ocf 107,857,000 CashFlowsFromUsedInOperatingActivities 2024-12-31
revenue 429,091,000 Revenue 2024-12-31

The ratios

The figures themselves rather than their scores — what somebody looking up VISTN.OL on one particular measure came for.

RatioValue
cash operating margin19.88
current ratio2.24
current ratio reported2.24
fcf margin25.14
interest cover5.86
operating margin19.88
owner earnings margin25.14
revenue growth-1.45
revenue growth per share-1.45
roic22.71
rule of 4018.43
sbc pct revenue0.0

What to be careful about

What this model itself distrusts about VISTN.OL's figures. Written by the derivation as it ran, not added afterwards.